114 related articles for article (PubMed ID: 38842119)
21. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
[TBL] [Abstract][Full Text] [Related]
22. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
[TBL] [Abstract][Full Text] [Related]
23. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
Serkies K; Jassem J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
[TBL] [Abstract][Full Text] [Related]
24. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
25. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
[TBL] [Abstract][Full Text] [Related]
26. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
27. Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.
Monk BJ; Toita T; Wu X; Vázquez Limón JC; Tarnawski R; Mandai M; Shapira-Frommer R; Mahantshetty U; Del Pilar Estevez-Diz M; Zhou Q; Limaye S; Godinez FJR; Oppermann Kussler C; Varga S; Valdiviezo N; Aoki D; Leiva M; Lee JY; Sulay R; Kreynina Y; Cheng WF; Rey F; Rong Y; Ke G; Wildsmith S; Lloyd A; Dry H; Tablante Nunes A; Mayadev J
Lancet Oncol; 2023 Dec; 24(12):1334-1348. PubMed ID: 38039991
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
29. CT-based image-guided brachytherapy in uterine cervical cancer: Effect of tumor dose and volume on local control.
Uezono H; Tsujino K; Inoue Y; Kajihara A; Marudai M; Bessho R; Sekii S; Kubota H; Yamaguchi S; Ota Y
Brachytherapy; 2022; 21(6):814-822. PubMed ID: 36155168
[TBL] [Abstract][Full Text] [Related]
30. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
31. Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.
Okonogi N; Wakatsuki M; Mizuno H; Fukuda S; Cao J; Kodrat H; Lau FN; Calaguas MJ; de Los Reyes RH; Chansilpa Y; Uddin AFMK; Adylkhanov T; Cho CK; Tsegmed U; Hoang NC; Ohno T; Nakano T; Kato S;
J Radiat Res; 2020 Jul; 61(4):608-615. PubMed ID: 32367130
[TBL] [Abstract][Full Text] [Related]
32. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
33. A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer.
Kawashima A; Isohashi F; Mabuchi S; Sawada K; Ueda Y; Kobayashi E; Matsumoto Y; Otani K; Tamari K; Seo Y; Suzuki O; Sumida I; Tomimatsu T; Kimura T; Ogawa K
J Radiat Res; 2019 Mar; 60(2):264-269. PubMed ID: 30649485
[TBL] [Abstract][Full Text] [Related]
34. A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I-II non-bulky cervical squamous cell carcinoma.
Yoshimoto Y; Murata K; Irie D; Ando K; Adachi A; Aoki H; Hirakawa T; Noda SE; Nakano T; Ohno T
J Radiat Res; 2022 Mar; 63(2):290-295. PubMed ID: 35152292
[TBL] [Abstract][Full Text] [Related]
35. A preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Choi EK; Kim JH; Ahn SD; Lee SW; Park HJ; Kim YT; Mok JE; Nam JH
Cancer Res Treat; 2005 Feb; 37(1):37-43. PubMed ID: 19956508
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
Liu C; Ran X; Wang Z; Zhang K
Chin Clin Oncol; 2023 Aug; 12(4):38. PubMed ID: 37699603
[TBL] [Abstract][Full Text] [Related]
37. Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysis.
Okonogi N; Wakatsuki M; Kato S; Murata H; Kiyohara H; Karasawa K; Ohno T; Tsuji H; Nakano T; Shozu M;
Cancer Med; 2020 Feb; 9(4):1400-1408. PubMed ID: 31891228
[TBL] [Abstract][Full Text] [Related]
38. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix.
Souhami L; Seymour R; Roman TN; Stanimir GW; Trudeau M; Clark BG; Freeman CR
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):871-8. PubMed ID: 8244817
[TBL] [Abstract][Full Text] [Related]
39. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
40. Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer.
Aghili M; Andalib B; Karimi Moghaddam Z; Maddah Safaie A; Amoozgar Hashemi F; Mousavi Darzikolaie N
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2745-2750. PubMed ID: 30360600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
